Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for heparin- binding epidermal growth factor- like growth factor
Most Correlated Studies
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
- L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
Most Relevant Literature
- An unanticipated discourse of HB-EGF with VANGL2 signaling during embryo implantation.
- Hypothyroidism induces motor deficit via altered cerebellar HB-EGF/EGFR and autophagy.
- Group 3 innate lymphoid cells produce the growth factor HB-EGF to protect the intestine from TNF-med…
- Attenuating influenza a virus infection by heparin binding EGF-like growth factor.
- MiR-183 impeded embryo implantation by regulating Hbegf and Lamc1 in mouse uterus.
Most Relevant Clinical Trials
- Endometrial Heparin-binding Epidermal Growth Factor Expression
- Urinary Cytokines in Patients With Overactive Bladder (OAB)
- Study Using IMC-A12 (Cixutumumab) With or Without Cetuximab in Participants With Metastatic Colorect…
- TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanc…
- ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer
